INmune Bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.54 | -$0.54 | -$0.54 |
| Q2 2024 | 1 | -$0.63 | -$0.63 | -$0.63 |
| Q3 2024 | 1 | -$0.51 | -$0.51 | -$0.51 |
| Q4 2024 | 3 | -$0.56 | -$0.56 | -$0.56 |
| Q1 2025 | 1 | -$0.47 | -$0.47 | -$0.47 |
| Q2 2025 | 1 | -$0.41 | -$0.41 | -$0.41 |
| Q3 2025 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q4 2025 | 1 | -$0.42 | -$0.42 | -$0.42 |
INmune Bio, Inc. Earnings Date And Information
INmune Bio, Inc. last posted its earnings results on Thursday, October 31st, 2024. The company reported $-0.6 earnings per share for the quarter, missing analysts' consensus estimates of $-0.49 by $0.11. The company had revenue of 0 for the quarter and had revenue of 155,000 for the year. INmune Bio, Inc. has generated $-2 earnings per share over the last year ($-1.67 diluted earnings per share) and currently has a price-to-earnings ratio of -2.38. INmune Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based on prior year's report dates.
INmune Bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/31/2024 | Q3 2024 | -$0.49 | -$0.60 | -0.11 | $333 | $0 |
| 08/01/2024 | Q2 2024 | -$0.63 | -$0.50 | 0.13 | $14,000 | $0 |
| 05/09/2024 | Q1 2024 | -$0.53 | -$0.61 | -0.08 | $14,000 | |
| 03/28/2024 | Q4 2023 | -$0.47 | $28,000 | |||
| 11/01/2023 | Q3 2023 | -$0.39 | -$0.48 | -0.09 | $46,000 | $43,000 |
| 08/07/2023 | Q2 2023 | -$0.40 | -$0.36 | 0.04 | $38,000 | $46,000 |
| 05/03/2023 | Q1 2023 | -$0.02 | -$0.37 | -0.35 | $38,000 | |
| 03/02/2023 | Q4 2022 | $0.48 | -$0.34 | -0.82 | $97,000 | |
| 11/02/2022 | Q3 2022 | -$0.59 | -$0.45 | 0.14 | $98,000 | |
| 08/03/2022 | Q2 2022 | -$0.50 | -$0.41 | 0.09 | $16,000 | |
| 05/05/2022 | Q1 2022 | -$0.60 | -$0.41 | 0.19 | $163,000 | |
| 03/03/2022 | Q4 2021 | -$0.56 | -$0.56 | 0 | $163,000 | |
| 11/03/2021 | Q3 2021 | -$0.43 | -$0.55 | -0.12 | $1.45 M | $14,000 |
| 08/04/2021 | Q2 2021 | -$0.33 | -$0.44 | -0.11 | $0 | |
| 05/05/2021 | Q1 2021 | -$0.28 | -$0.32 | -0.04 | $4,000 | |
| 03/04/2021 | Q4 2020 | -$0.33 | -$0.25 | 0.08 | $10,916 | |
| 11/05/2020 | Q3 2020 | -$0.17 | -$0.36 | -0.19 | $0 | |
| 08/05/2020 | Q2 2020 | -$0.20 | -$0.20 | 0 | $0 | |
| 05/13/2020 | Q1 2020 | -$0.21 | -$0.19 | 0.02 | $0 | |
| 03/10/2020 | Q4 2019 | -$0.25 | -$0.22 | 0.03 | $77.69 M |
INmune Bio, Inc. Earnings: Frequently Asked Questions
-
When is INmune Bio, Inc.'s earnings date?
INmune Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based off last year's report dates.
-
How can I listen to INmune Bio, Inc.'s earnings conference call?
The conference call for INmune Bio, Inc.'s latest earnings report can be listened to online.
-
How can I read INmune Bio, Inc.'s conference call transcript?
The conference call transcript for INmune Bio, Inc.'s latest earnings report can be read online.
-
How much revenue does INmune Bio, Inc. generate each year?
INmune Bio, Inc. (:INMB) has a recorded annual revenue of $155,000.
-
How much profit does INmune Bio, Inc. generate each year?
INmune Bio, Inc. (:INMB) has a recorded net income of $155,000. INmune Bio, Inc. has generated $-1.67 earnings per share over the last four quarters.
-
What is INmune Bio, Inc.'s price-to-earnings ratio?
INmune Bio, Inc. (:INMB) has a price-to-earnings ratio of -2.38 and price/earnings-to-growth ratio is 0.41.
